Incidence of extended spectrum beta-lactamase (ESBL)-producing enterobacteria in the area of Caltagirone (Sicily);Frequenza di enterobatteri produttori di beta-lattamasi a spettro esteso (ESBL) nell'area di Caltagirone (Sicilia)

Infezioni in Medicina

Volumn 12, Issue 2, 2004, Pages 108-112

  Bellissima, Pietro ^a   Amato, Rosalba ^a  

^a UOC di Malattie Infettive ^*  (Italy)

Author keywords

Enterobacteria; ESBL

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER KOSERI; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; IN VITRO STUDY; INCIDENCE; ITALY; KLEBSIELLA; NONHUMAN;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITAL DEPARTMENTS; HOSPITALS, DISTRICT; HUMANS; SICILY; SUBSTRATE SPECIFICITY;

EID: 3242705847     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rupp M.E., Fey P.D. Extended spectrum beta-lactamases (ESBL) - producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 63 (4), 353-365, 2003.
2. Segatore B., Franceschini N. Cefotaxime, des-cefotaxime and ceftazidime: in vitro activity and stability to hydrolysis from TEM-derived extended spectrum beta-lactamases. Infez. Med. 1, 16-20, 2002.
3. Amyes S.G.B., Miles R.S. Extended-spectrum β-lactamases: the role of inhibitors in terapy. J. Antimicrob. Chemother. 42, 415-417, 1998.
4. Larson L.L., Ramphal R. Extended-spectrum β-lactamases. Semin. Respir. Infect. 17 (3), 189-194, 2002.
5. Heritage J. et al. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. J. Antimicrob. Chemoter. 44 (3), 309-318, 1999.
6. Laksai Y. et al. First identification of an SHV-12 extended-spectrum β-lactamases in Klebsiella pneumoniae isolated in Italy. J. Antimicrob. Chemoter. 45 (3), 349-351, 2000.
7. Pecile P., Nicoletti P.L. Prevalenza di Enterobatteri produttori di β-lattamasi a spettro esteso (ESBL) isolati da pazienti ricoverati nei reparti dell'azienda ospedaliera di Careggi. Bollettino medico dell'Az. Osp. di Careggi n° 8 - Aprile 1997.
8. Goossens H. for the MYSTIC Study Group (Europe) results from Europe: comparison of antibiotic susceptibilities between countries and centre types. J. Antimicrob. Chemother. 46 (Suppl. T2), 39-52, 2000.
9. Xiong Z., Zhu D., Zhang Y., Wang F. Extended-spectrum β-lactamases in K. pneumoniae and Escherichia coli isolates. Zhonghua Yi Xue Za Zhi 82 (21), 1476-9, 2002.
10. Privitera G. Sorveglianza delle resistenze batteriche nelle Enterobacteriaceae: risultati di uno studio multicentrico nazionale. XXV Congresso Associazione Microbiologi Italiani, Pesaro, 1996.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobioal susceptibility tests for bacteria that grow aerobically. Approved standard M7 A5. Ed. Wayne, PA: NCCL, 2000.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobioal susceptibility tests for bacteria that grow aerobically. Approved standard M-100-S10: performance standard for antimicrobiol susceptibility testing, Ed. Wayne, PA: NCCL, 2000.
13. Paterson D.L., Ko W.C., Von Gottberg A. et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med. 6, 140 (1), 26-32, 2004.
14. Gupta A., Ampofo K., Rubenstein D., Saiman L. Extended spectrum β-lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J. Perinatol. 23(6), 439-443, 2003.
15. MacKenzie F.M., Gould I.M. Extended spectrum β-lactamases. J. Infect. 36 (3), 255-258, 1998.
16. Bellissima P., Amato R., Bonfante S. Monitoraggio delle resistenze agli antibiotici di batteri isolati in ospedale. Infez. Med. 4, 211-215, 2000.
17. Fontana R., Cornaglia G., Lo Cascio G. Fenotipi di resistenza ai beta-lattamici e agli aminoglicosidi in Klebsiella pneumoniae ed Escherichia coli. Microbiologia Medica 14, 3 (S2), 12-17, 1999.